MedTrace Logo

Optimizing Outcomes for Young Autistic Children

NCT05926687 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2026-01-29

No results posted yet for this study

Summary

The overarching goal of the proposed study is to: (a) determine how best to sequence two parent-mediated interventions: a social communication intervention (Project ImPACT, Improving Parents as Communication Teachers) and a disruptive behavior intervention (Parent Training for Disruptive Behavior) and (b) examine moderators and mediators of intervention outcomes.

Conditions

Interventions

BEHAVIORAL

Social Communication

Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour twice/week

BEHAVIORAL

Disruptive Behavior

Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour once/week

BEHAVIORAL

Social Communication + Reduce Frequency

Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour once/week

BEHAVIORAL

Social Communication + Add Tools

Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour twice/week

BEHAVIORAL

Disruptive Behavior + Reduce Frequency

Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour every other week

BEHAVIORAL

Disruptive Behavior + Add Tools

Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour once/week

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Months
Max Age
48 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926687 on ClinicalTrials.gov